Linked Life Data

17102762

Source:http://linkedlifedata.com/resource/pubmed/id/17102762

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2006-11-14
pubmed:abstractText
Few effective treatment options are available for patients with advanced hepatocellular carcinoma (HCC). Some transplant centers have begun offering living donor liver transplantation (LDLT) for selected patients whose HCC exceeds Milan criteria by a small margin. However, this remains a controversial subject. In this article, we weigh the arguments for and against LDLT for advanced HCC. Because donor autonomy forms the crux of this dilemma, the real question becomes: to whom does the decision belong, the individual donors or the medical community? We argue that donor autonomy should not be paramount in settings where the recipient benefit is uncertain.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1136-9
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.
pubmed:affiliation
Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109-0362, USA. mvolk@med.umich.edu
pubmed:publicationType
Journal Article, Review